Screener
Charles River Laboratories CRL RMS — SG&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Costs and expenses | ||||
| Cost of services provided (excluding amortization of intangible assets) | 552,007 | 584,876 | 1,160,914 | 1,162,304 |
| Cost of products sold (excluding amortization of intangible assets) | 88,697 | 90,192 | 180,956 | 179,200 |
| Selling, general and administrative | 228,897 | 191,549 | 388,319 | 369,348 |
| Amortization of intangible assets | 14,589 | 65,384 | 29,934 | 130,648 |
| Operating income | 119,888 | 100,134 | 239,785 | 174,803 |
| Other income (expense) | ||||
| Interest income | 1,032 | 1,097 | 2,065 | 2,501 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's RMS — SG&A?
- Charles River Laboratories (CRL) reported RMS — SG&A of $26.5M in Q2 2026.
- How has Charles River Laboratories's RMS — SG&A changed year-over-year?
- Charles River Laboratories's RMS — SG&A decreased by 6.6% year-over-year, from $28.37M to $26.5M.
- What is the long-term trend for Charles River Laboratories's RMS — SG&A?
- Over 3 years (2022 to 2025), Charles River Laboratories's RMS — SG&A has grown at a -0.4% compound annual growth rate (CAGR), from $102.8M to $101.53M.
- What does RMS — SG&A mean?
- Captures the indirect operating expenses incurred by the Research Models and Services segment to support its business activities, including sales, marketing, and general management overhead. These costs are essential for maintaining the segment's market presence and administrative infrastructure. It is a key metric for evaluating the segment's operational leverage.
Ask your AI about Charles River Laboratories's rms — sg&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude